Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis
| Үндсэн зохиолчид: | , , , , , , , , , , |
|---|---|
| Формат: | Conference item |
| Хэл сонгох: | English |
| Хэвлэсэн: |
Journal of Rheumatology
2022
|
| Тойм: |
|---|